BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced plans to accelerate partnering initiatives and scale back discovery research spending over the next 24 months to ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Solar energy play Array Technologies (US:ARRY) has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results